Bundgaard H, Enevoldsen M T, Kjeldsen K
Department of Medicine B, The Heart Centre, Rigshospitalet, National University Hospital, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark.
J Mol Cell Cardiol. 1998 Oct;30(10):2037-46. doi: 10.1006/jmcc.1998.0764.
The effects of high K intake on plasma K, myocardial K content and Na,K-ATPase concentration and on myocardial K uptake during KCl infusion were evaluated in rodents. Myocardial Na,K-ATPase was quantified in crude homogenates by K-dependent pNPPase activity in rats, and in intact samples by3H-ouabain binding in guinea pigs. Na, K-ATPase alpha isoform distribution was assessed by immunoblotting. Plasma K was monitored in anesthetized rats during intravenous infusion of 0.75 mmol KCl/100 g body weight/h. A significant increase in plasma K was observed after 2 days of K supplementation, 4.9+/-0.2 (mean+/-s.e.m.)v 3.0+/-0.2 mmol/l in weight matched controls ( P<0.01,n=5) and this difference remained stable. After 1 day, a significant myocardial K content increase was obtained, 86. 2+/-3.0v 76.7+/-1.9 micromol/g wet weight (P<0.05, n=5); after 4 days myocardial K stabilized 4.9+/-1.2 micromol/g wet weight above control level (P<0.05,n=5). From the 4th day, a significant decrease in myocardial K-dependent pNPPase activity was observed, 1.18+/-0.04v 1. 31+/-0.01 micromol/min/g wet weight in weight matched controls (P<0. 05,n=5); after 2 weeks the decrease was 29% (P<0.05,n=5), with a reduction in alpha1-isoform abundance by 24% (P<0.05,n=5), and a tendency to a decrease in alpha2 of 10% (n.s.,n=5). The measurements were validated by 3H-ouabain binding to myocardial samples from guinea pigs K-supplemented for 2 weeks, showing a decrease of 21% (P<0.05,n=5). During KCl infusion, the myocardial K content increase rate was reduced by 52% (P<0.05) in the K-supplemented rats. The observed effects of K-supplementation on plasma K, myocardial K content and myocardial K-dependent pNPPase activity were abolished within 2 days after reallocation to chow with normal K content. In conclusion, high K-intake is associated with significantly and reversible increased plasma and myocardial K content, and decreased myocardial Na,K-ATPase concentration and net myocardial K uptake capacity. Thus, the heart is protected from major increases in intracellular K concentrations during chronically-high K-intake.
在啮齿动物中评估了高钾摄入对血浆钾、心肌钾含量、钠钾 - ATP酶浓度以及氯化钾输注期间心肌钾摄取的影响。通过大鼠粗匀浆中钾依赖性对硝基苯磷酸酶(pNPPase)活性对心肌钠钾 - ATP酶进行定量,通过豚鼠完整样本中的³H - 哇巴因结合进行定量。通过免疫印迹评估钠钾 - ATP酶α同工型分布。在麻醉大鼠静脉输注0.75 mmol氯化钾/100 g体重/小时期间监测血浆钾。补钾2天后观察到血浆钾显著升高,体重匹配的对照组为4.9±0.2(平均值±标准误)对3.0±0.2 mmol/L(P<0.01,n = 5),且这种差异保持稳定。1天后,心肌钾含量显著增加,为86.2±3.0对76.7±1.9 μmol/g湿重(P<0.05,n = 5);4天后心肌钾稳定在比对照水平高4.9±1.2 μmol/g湿重(P<0.05,n = 5)。从第4天起,观察到心肌钾依赖性pNPPase活性显著降低,体重匹配的对照组为1.18±0.04对1.31±0.01 μmol/分钟/g湿重(P<0.05,n = 5);2周后降低了29%(P<0.05,n = 5),α1同工型丰度降低了24%(P<0.05,n = 5),α2有降低10%的趋势(无统计学意义,n = 5)。通过对补钾2周的豚鼠心肌样本进行³H - 哇巴因结合验证了这些测量结果,显示降低了21%(P<0.05,n = 5)。在氯化钾输注期间,补钾大鼠的心肌钾含量增加率降低了52%(P<0.05)。在重新给予正常钾含量的饲料后2天内,观察到的补钾对血浆钾、心肌钾含量和心肌钾依赖性pNPPase活性的影响消失。总之,高钾摄入与血浆和心肌钾含量显著且可逆的增加以及心肌钠钾 - ATP酶浓度和心肌净钾摄取能力降低有关。因此,在长期高钾摄入期间,心脏可免受细胞内钾浓度的大幅增加。